Cognition Therapeutics(CGTX) - 2023 Q2 - Quarterly Report

1. Description of Business and Financial Condition On December 23, 2022, the Company filed a Registration Statement on Form S-3 (File No. 333- 268992) (the "Shelf") with the Securities and Exchange Commission ("SEC") in relation to the registration of common stock, preferred stock, debt securities, warrants, subscription rights, and/or units of any combination thereof of up to $200,000 in aggregate. The Shelf was declared effective on January 3, 2023 by the SEC. The Company also simultaneously entered into ...